104 related articles for article (PubMed ID: 9781598)
1. Biochemical modulation of 5-fluorouracil by methotrexate in patients with advanced gastric carcinoma.
Pérez JE; Lacava JA; Dominguez ME; Rodriguez R; Barbieri MR; Ortiz EH; Romero Acuña LA; Langhi MJ; Romero Acuña JM; Vallejo CT; Leone BA; Machiavelli MR; Romero AO
Am J Clin Oncol; 1998 Oct; 21(5):452-7. PubMed ID: 9781598
[TBL] [Abstract][Full Text] [Related]
2. Double modulation of 5-fluorouracil by methotrexate and high-dose L-leucovorin in advanced colorectal cancer.
Romero AO; Perez JE; Cuevas MA; Lacava JA; Sabatini CL; Dominguez ME; Rodriguez R; Barbieri MR; Ortiz EH; Salvadori MA; Acuña LA; Acuña JM; Langhi MJ; Amato S; Machiavelli MR; Leone BA; Vallejo CT; Lorusso V; DeLena M
Am J Clin Oncol; 1998 Feb; 21(1):94-8. PubMed ID: 9499269
[TBL] [Abstract][Full Text] [Related]
3. Double modulation of 5-fluorouracil by trimetrexate and leucovorin in patients with advanced colorectal carcinoma.
Machiavelli MR; Salum G; Pérez JE; Ortiz EH; Romero AO; Bologna F; Vallejo CT; Lacava JA; Dominguez ME; Leone BA
Am J Clin Oncol; 2004 Apr; 27(2):149-54. PubMed ID: 15057154
[TBL] [Abstract][Full Text] [Related]
4. Double-modulation of 5-Fluorouracil by methotrexate and leucovorin in advanced colorectal-carcinoma.
Leone B; Romero A; Rabinovich M; Vallejo C; Bianco A; Perez J; Rodriguez R; Cuevas M; Machiavelli M; Paris A; Lacava J
Int J Oncol; 1993 Nov; 3(5):995-9. PubMed ID: 21573464
[TBL] [Abstract][Full Text] [Related]
5. Advanced colorectal carcinoma. A prospective randomized trial of sequential methotrexate, 5-fluorouracil, and leucovorin versus 5-fluorouracil alone.
Machiavelli M; Leone BA; Romero A; Rabinovich MG; Vallejo CT; Bianco A; Pérez JE; Rodríguez R; Cuevas MA; Alvarez LA
Am J Clin Oncol; 1991 Jun; 14(3):211-7. PubMed ID: 2031508
[TBL] [Abstract][Full Text] [Related]
6. Effect of a 3-hour interval between methotrexate and 5-fluorouracil in the treatment of metastatic colorectal cancer.
Matsumura Y; Haruyama K; Hamaguchi T; Shirao K; Muro K; Yamada Y; Shimada Y; Sugano K
Jpn J Clin Oncol; 2002 Jan; 32(1):9-13. PubMed ID: 11932356
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
Hudes GR; Lipsitz S; Grem J; Morrisey M; Weiner L; Kugler JW; Benson A
Cancer; 1999 Jan; 85(2):290-4. PubMed ID: 10023694
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
[TBL] [Abstract][Full Text] [Related]
9. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.
Petrelli N; Herrera L; Rustum Y; Burke P; Creaven P; Stulc J; Emrich LJ; Mittelman A
J Clin Oncol; 1987 Oct; 5(10):1559-65. PubMed ID: 2443619
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of sequential methotrexate and 5-fluorouracil chemotherapy in previously treated gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group, JCOG 9207 trial.
Hamaguchi T; Shirao K; Yamamichi N; Hyodo I; Koizumi W; Seki S; Imamura T; Honma H; Ohtsu A; Boku N; Mukai T; Yamamoto S; Fukuda H; Yoshida S;
Jpn J Clin Oncol; 2008 Jun; 38(6):432-7. PubMed ID: 18515821
[TBL] [Abstract][Full Text] [Related]
11. A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer.
Chen LT; Liu TW; Wu CW; Chung TR; Shiah HS; Jan CM; Liu JM; Whang-Peng J; Chang JY
Oncology; 2002; 63(3):239-47. PubMed ID: 12381903
[TBL] [Abstract][Full Text] [Related]
12. Double modulation of 5-fluorouracil by leucovorin and low-dose methotrexate in advanced colorectal cancer.
Stabuc B; Markovic A; Plesnicar A; Cizej TE
Neoplasma; 2000; 47(4):248-52. PubMed ID: 11043831
[TBL] [Abstract][Full Text] [Related]
13. Biochemical modulation of 5-fluorouracil with methotrexate in advanced colorectal cancer patients pretreated with adjuvant 5-fluorouracil and leucovorin.
Pronzato P; Vaira F; Vigani A; Losardo P; Bertelli G
Anticancer Res; 1995; 15(6B):2679-82. PubMed ID: 8669846
[TBL] [Abstract][Full Text] [Related]
14. Phase I-II study of 5-fluorouracil, leucovorin, doxorubicin, methotrexate, and long-term oral etoposide (FLAME) in unresectable or metastatic gastric cancer.
Bjarnason GA; Cripps C; Goel R; Fine S; Oza AM; Skillings JR; Kerr I; Germond CJ; Moore MJ; Maroun JA; Franssen E; Dulude H
Am J Clin Oncol; 1998 Dec; 21(6):537-42. PubMed ID: 9856651
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin as first-line chemotherapy in patients with advanced gastric cancer.
Wang F; Wang Z; Zhou N; An X; Xu R; He Y; Li Y
Am J Clin Oncol; 2011 Aug; 34(4):401-5. PubMed ID: 21791984
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of sequential high-dose methotrexate (MTX) and 5-fluorouracil (F) alternated with epirubicin (E) and cisplatin (P) [FEMTX-P] in advanced gastric cancer.
Roelofs EJ; Wagener DJ; Conroy T; Wils J; Burghouts JT; Fickers M; de Graeff A; Lalisang F; Paillot B
Ann Oncol; 1993 May; 4(5):426-8. PubMed ID: 8353077
[TBL] [Abstract][Full Text] [Related]
17. Concurrent modulation of 5-fluorouracil with methotrexate and L-leucovorin: an effective and moderately toxic regimen for the treatment of advanced colorectal carcinoma. A multicenter phase II study of the Southern Italy Cooperative Oncology Group.
Comella P; Lorusso V; Casaretti R; De Lucia L; Cartení G; Manzione L; Mancarella S; De Lena M; Comella G
Tumori; 1999; 85(6):465-72. PubMed ID: 10774567
[TBL] [Abstract][Full Text] [Related]
18. A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer. The Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).
Aranda E; Cervantes A; Dorta J; Blanco E; Fernández-Martos C; Cruz-Hernandez JJ; Carrato A; Gonzalez-Mancha R; García-Conde J; Díaz-Rubio E
Cancer; 1995 Aug; 76(4):559-63. PubMed ID: 8625147
[TBL] [Abstract][Full Text] [Related]
19. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer.
Yeh KH; Lu YS; Hsu CH; Lin JF; Hsu C; Kuo SH; Li SJ; Cheng AL
Oncology; 2005; 69(1):88-95. PubMed ID: 16088236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]